FDA head calls for probe into Alzheimer’s drug review
Dr. Janet Woodcock announced the extraordinary step via Twitter. It's the latest fallout over last month's approval of Aduhelm, an expensive and unproven therapy that the agency OK'd against the advice of its own outside experts.
Pfizer to seek approval for 3rd vaccine dose, says it could ward off delta variant
The company said Thursday that another shot could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.
FDA trims use of contentious Alzheimer’s drug amid backlash
The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer's drug.
U.S. to resume Johnson & Johnson COVID-19 vaccinations despite rare clot risk
Advisers to the Centers for Disease Control and Prevention said Friday the benefits of the single-dose COVID-19 shot outweigh a rare risk of blood clots.
If granted emergency use, Johnson & Johnson's vaccine would be the third available vaccine in the United States, but the first to require one dose rather than two.
It's expected to make it easier for people to stay on track with their HIV medicines and to do so with more privacy. Not long ago, patients had to take multiple pills several times a day to control infection with…
Dr. David Kessler, who will have the title of chief science officer of COVID response, headed the Food and Drug Administration in the 1990s under presidents of both political parties.
The first Americans vaccinated against COVID-19 are getting their second dose, while Britain has decided to postpone boosters and focus instead on giving more people a first shot — international differences that are adding to public confusion.
Shots for health workers and nursing home residents are expected to begin in the coming days after the Food and Drug Administration authorized an emergency rollout of what promises to be a strongly protective vaccine from Pfizer Inc. and its…
Additional Support Provided By:
